# Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast

> **NCT04597892** · — · WITHDRAWN · sponsor: **Maastricht University Medical Center**

## Conditions studied

- Renal Insufficiency
- Acute Kidney Injury
- Contrast-induced Nephropathy

## Interventions

- **DIAGNOSTIC_TEST:** serum creatinine assay

## Key facts

- **NCT ID:** NCT04597892
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2097-05-01
- **Primary completion:** 2099-03-01
- **Final completion:** 2099-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** delay
- **Last updated:** 2023-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04597892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04597892, "Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04597892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*